Ajanta Pharma will soon launch its generic montelukast tablets and oral granules that helps in treating asthma and seasonal hay fever.
![Indian Pharamaceutical Company Receives USFDA’s Nod for Asthma Treatment Drugs Indian Pharamaceutical Company Receives USFDA’s Nod for Asthma Treatment Drugs](https://images.medindia.net/health-images/1200_1000/asthma-women1.jpg)
While the approval is for montelukast tablets in the strength of 10 mg, montelukast sodium chewable tablets have received nod for strengths of 4mg and 5 mg. The company plans to launch the generic products shortly, it added.
Montelukast 4mg chewable tablets are for 2 to 5 year old patients, 5mg tablets are for patients from 6 to 14 years of age and Montelukast oral granules are specially appropriate for patients of 12 months of age and older.
"For 12 months ending June 2015, montelukast tablets, chewable tablets and granules had sales of approximately $237 million, $87 million and $31 million respectively," said Ajanta Pharma.
Ajanta Pharma is among the fastest growing pharmaceutical companies in the indian market. Its main focus is on fast growing therapeutic segments of Cardiology, Ophthalmology, Dermatology and Pain Management.
Source-Medindia